| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sheena Jonathan | Director, CO-FOUNDER | C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN | /s/ Tami Chen, Attorney-in-Fact | 27 Jan 2026 | 0001646649 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTRA | Common Stock | Sale | $38,770 | -160 | -0.71% | $242.31 | 22,372 | 23 Jan 2026 | By Caraluna 1 Trust | F1, F2, F3 |
| transaction | NTRA | Common Stock | Sale | $45,046 | -185 | -0.83% | $243.49 | 22,187 | 23 Jan 2026 | By Caraluna 1 Trust | F1, F3, F4 |
| transaction | NTRA | Common Stock | Sale | $86,897 | -355 | -1.6% | $244.78 | 21,832 | 23 Jan 2026 | By Caraluna 1 Trust | F1, F3, F5 |
| transaction | NTRA | Common Stock | Sale | $12,281 | -50 | -0.23% | $245.62 | 21,782 | 23 Jan 2026 | By Caraluna 1 Trust | F1, F3 |
| transaction | NTRA | Common Stock | Sale | $48,446 | -200 | -0.89% | $242.23 | 22,332 | 23 Jan 2026 | By Caraluna 2 Trust | F1, F3, F6 |
| transaction | NTRA | Common Stock | Sale | $38,974 | -160 | -0.72% | $243.59 | 22,172 | 23 Jan 2026 | By Caraluna 2 Trust | F1, F3, F7 |
| transaction | NTRA | Common Stock | Sale | $95,500 | -390 | -1.8% | $244.87 | 21,782 | 23 Jan 2026 | By Caraluna 2 Trust | F1, F3, F8 |
| holding | NTRA | Common Stock | 264,078 | 23 Jan 2026 | Direct |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. |
| F2 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.02 to $242.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. |
| F4 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.1250 to $243.9700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.3759 to $245.1850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.13 to $242.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.34 to $243.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.4550 to $245.3900 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |